Pharma
Viatris Inc.
1
Articles
Competitor
Top Role
Apr 7, 2026
First Mention
Apr 7, 2026
Last Mention
0.67
Relevance Score
Coverage Timeline
April 2026
Novartis Spins Off Sandoz: What the $10B Pure-Play Means for Biosimilar Strategies and Drug Pricing 2025-2026
Deals
Competitor
Apr 7, 2026
Amgen, Viatris, Boehringer Ingelheim, they all have their sites set on Humira and Neulasta biosimilar shares.